296 related articles for article (PubMed ID: 31974102)
1. Reduction in Global Myocardial Glucose Metabolism in Subjects With 1-Hour Postload Hyperglycemia and Impaired Glucose Tolerance.
Succurro E; Pedace E; Andreozzi F; Papa A; Vizza P; Fiorentino TV; Perticone F; Veltri P; Cascini GL; Sesti G
Diabetes Care; 2020 Mar; 43(3):669-676. PubMed ID: 31974102
[TBL] [Abstract][Full Text] [Related]
2. Duodenal Sodium/Glucose Cotransporter 1 Expression Under Fasting Conditions Is Associated With Postload Hyperglycemia.
Fiorentino TV; Suraci E; Arcidiacono GP; Cimellaro A; Mignogna C; Presta I; Andreozzi F; Hribal ML; Perticone F; Donato G; Luzza F; Sesti G
J Clin Endocrinol Metab; 2017 Nov; 102(11):3979-3989. PubMed ID: 28938485
[TBL] [Abstract][Full Text] [Related]
3. One-Hour Postload Hyperglycemia Is a Stronger Predictor of Type 2 Diabetes Than Impaired Fasting Glucose.
Fiorentino TV; Marini MA; Andreozzi F; Arturi F; Succurro E; Perticone M; Sciacqua A; Hribal ML; Perticone F; Sesti G
J Clin Endocrinol Metab; 2015 Oct; 100(10):3744-51. PubMed ID: 26274345
[TBL] [Abstract][Full Text] [Related]
4. Elevated 1-hour postload plasma glucose levels identify subjects with normal glucose tolerance but impaired β-cell function, insulin resistance, and worse cardiovascular risk profile: the GENFIEV study.
Bianchi C; Miccoli R; Trombetta M; Giorgino F; Frontoni S; Faloia E; Marchesini G; Dolci MA; Cavalot F; Cavallo G; Leonetti F; Bonadonna RC; Del Prato S;
J Clin Endocrinol Metab; 2013 May; 98(5):2100-5. PubMed ID: 23539736
[TBL] [Abstract][Full Text] [Related]
5. Impaired early- but not late-phase insulin secretion in subjects with impaired fasting glucose.
Kanat M; Norton L; Winnier D; Jenkinson C; DeFronzo RA; Abdul-Ghani MA
Acta Diabetol; 2011 Sep; 48(3):209-17. PubMed ID: 21553243
[TBL] [Abstract][Full Text] [Related]
6. Insulin sensitivity, β-cell function, and incretin effect in individuals with elevated 1-hour postload plasma glucose levels.
Marini MA; Succurro E; Frontoni S; Mastroianni S; Arturi F; Sciacqua A; Lauro R; Hribal ML; Perticone F; Sesti G
Diabetes Care; 2012 Apr; 35(4):868-72. PubMed ID: 22357182
[TBL] [Abstract][Full Text] [Related]
7. Glucose Homeostatic Law: Insulin Clearance Predicts the Progression of Glucose Intolerance in Humans.
Ohashi K; Komada H; Uda S; Kubota H; Iwaki T; Fukuzawa H; Komori Y; Fujii M; Toyoshima Y; Sakaguchi K; Ogawa W; Kuroda S
PLoS One; 2015; 10(12):e0143880. PubMed ID: 26623647
[TBL] [Abstract][Full Text] [Related]
8. Insulin sensitivity and first-phase insulin secretion in obese Chinese with hyperglycemia in 30 and/or 60 min during glucose tolerance tests.
Hong J; Zhang YF; Gu WQ; Zhang YW; Su YX; Chi ZN; Wang WQ; Li XY; Ning G
Endocrine; 2008; 34(1-3):75-80. PubMed ID: 18979203
[TBL] [Abstract][Full Text] [Related]
9. Metabolic characteristics of subjects with normal glucose tolerance and 1-h hyperglycaemia.
Qian L; Fu X; Xu L; Zheng S; Zhou W; Wang X; Gu Y; Lin F; Luo M
Clin Endocrinol (Oxf); 2008 Oct; 69(4):575-9. PubMed ID: 18248638
[TBL] [Abstract][Full Text] [Related]
10. Pathogenesis of prediabetes: role of the liver in isolated fasting hyperglycemia and combined fasting and postprandial hyperglycemia.
Basu R; Barosa C; Jones J; Dube S; Carter R; Basu A; Rizza RA
J Clin Endocrinol Metab; 2013 Mar; 98(3):E409-17. PubMed ID: 23345093
[TBL] [Abstract][Full Text] [Related]
11. Metabolic characteristics of individuals with impaired fasting glucose and/or impaired glucose tolerance.
Weyer C; Bogardus C; Pratley RE
Diabetes; 1999 Nov; 48(11):2197-203. PubMed ID: 10535454
[TBL] [Abstract][Full Text] [Related]
12. Risk of future diabetes is as high with abnormal intermediate post-glucose response as with impaired glucose tolerance.
Viswanathan V; Clementina M; Nair BM; Satyavani K
J Assoc Physicians India; 2007 Dec; 55():833-7. PubMed ID: 18405128
[TBL] [Abstract][Full Text] [Related]
13. Impact of glucagon response on postprandial hyperglycemia in men with impaired glucose tolerance and type 2 diabetes mellitus.
Henkel E; Menschikowski M; Koehler C; Leonhardt W; Hanefeld M
Metabolism; 2005 Sep; 54(9):1168-73. PubMed ID: 16125528
[TBL] [Abstract][Full Text] [Related]
14. Pathogenetic mechanisms of impaired glucose tolerance and type II diabetes in African-Americans. The significance of insulin secretion, insulin sensitivity, and glucose effectiveness.
Osei K; Gaillard T; Schuster DP
Diabetes Care; 1997 Mar; 20(3):396-404. PubMed ID: 9051394
[TBL] [Abstract][Full Text] [Related]
15. The potential role of the osteopontin-osteocalcin-osteoprotegerin triad in the pathogenesis of prediabetes in humans.
Daniele G; Winnier D; Mari A; Bruder J; Fourcaudot M; Pengou Z; Hansis-Diarte A; Jenkinson C; Tripathy D; Folli F
Acta Diabetol; 2018 Feb; 55(2):139-148. PubMed ID: 29151224
[TBL] [Abstract][Full Text] [Related]
16. Circulating fibroblast growth factor-21 is elevated in impaired glucose tolerance and type 2 diabetes and correlates with muscle and hepatic insulin resistance.
Chavez AO; Molina-Carrion M; Abdul-Ghani MA; Folli F; Defronzo RA; Tripathy D
Diabetes Care; 2009 Aug; 32(8):1542-6. PubMed ID: 19487637
[TBL] [Abstract][Full Text] [Related]
17. One-hour postload plasma glucose levels and left ventricular mass in hypertensive patients.
Sciacqua A; Miceli S; Carullo G; Greco L; Succurro E; Arturi F; Sesti G; Perticone F
Diabetes Care; 2011 Jun; 34(6):1406-11. PubMed ID: 21515837
[TBL] [Abstract][Full Text] [Related]
18. Sex-specific differences in myocardial glucose metabolic rate in non-diabetic, pre-diabetic and type 2 diabetic subjects.
Succurro E; Vizza P; Cicone F; Cassano V; Massimino M; Giofrè F; Fiorentino TV; Perticone M; Sciacqua A; Guzzi PH; Veltri P; Andreozzi F; Cascini GL; Sesti G
Cardiovasc Diabetol; 2024 Apr; 23(1):144. PubMed ID: 38671460
[TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor alpha and insulin resistance in obese type 2 diabetic patients.
Miyazaki Y; Pipek R; Mandarino LJ; DeFronzo RA
Int J Obes Relat Metab Disord; 2003 Jan; 27(1):88-94. PubMed ID: 12532159
[TBL] [Abstract][Full Text] [Related]
20. Retinol-binding protein 4 is associated with impaired glucose tolerance but not with whole body or hepatic insulin resistance in Mexican Americans.
Chavez AO; Coletta DK; Kamath S; Cromack DT; Monroy A; Folli F; DeFronzo RA; Tripathy D
Am J Physiol Endocrinol Metab; 2009 Apr; 296(4):E758-64. PubMed ID: 19190263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
